Taup, Dita P.
HRN: 07-36-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
07/17/2024
07/17/2024
IV
80 Mg
Once
IJ Cath Prophylaxis
Waiting Final Action
Indication: ProphylaxisEmpirical De-escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes